Compare Enveric Biosciences Inc (ENVB) vs Ishares Msci Brazil ETF (EWZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Ishares Msci Brazil ETF — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Ishares Msci Brazil ETF trades at $42.86 (market cap $10.93B). The key difference: Ishares Msci Brazil ETF is far larger — about 1633.8× Enveric Biosciences Inc's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Ishares Msci Brazil ETF for 50 Days on average.
| ENVB | EWZ | |
|---|---|---|
Market Cap | $6.69M | $10.93B |
Volume | 41,141 | 45,143,031 |
Sector | Health | Broad Market / Factor |
52-Week High | $10.80 | $43.00 |
52-Week Low | $1.27 | $28.79 |
Typical Hold Time | 14 Days | 50 Days |
Enterprise Value | -$1.60M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
EWZ, the iShares MSCI Brazil ETF, trades at $42.37, down 1.47% today. The technical outlook is bullish based on moving averages but shows overbought signals with RSI readings above 70. Recent news highlights significant investor focus on Brazil's upcoming October election, with unusual options activity and institutional positioning indicating market anticipation of policy impacts.
The ETF offers diversification from U.S. markets with exposure to Brazilian commodities and financials. Key risks include election volatility and U.S. trade tariffs. Institutional buying and analyst views suggest cautious optimism, but high RSI levels warrant attention for near-term price pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →
